Compound intended for oral absorption of nicotine with the aim of quitting smoking

摘要

The compound intended for the oral application of nicotine to the circulatory system and distribution to the central nervous system, applicable in colloidal form or in the form of an atomizing device in order to quit smoking or its replacement in the case of being the conditions for Unfavorable smoking In accordance with the invention in reference, the compound stands out for the fact that it contains a solution of nicotine in the form of a base and / or its salts with an organic acid in a concentration of 0.10 to 4.00% of the weight, the most appropriate concentration is 0.20 to 1.00% of the weight. It also contains materials that have a mucolytic effect of the acetylcysteine group in a concentration of 3.00 to 30.0% of the weight and / or phytocomplexes that have a mucolytic effect, acquired by extracting the selected plants from the Primula veris, Primula elatior group Hedera helix, Eucalyptus globulus nebo Liquiritia glabra in a concentration of 0.50 to 15.00% of the phytocomplex weight with an antioxidant effect selected from the group of flavones, flavonols, flavanones flavanones, isoflavones, neoflavonoids, anthocyanidins, pro-anthocyanins and their oligomers and polymers, acquired by extracting Camellia sinensis, Curcuma longa, Rosmarinus officinalis, Sylibium marianum, Vitis vinifera, Ginkgo biloba, Euterpe oleracea, Vaccinium myrtillus, Morinda citrifolia, Malpighia glabra plants, which also contain a retarder (buffer) which modifies acidity at a pH range of 7.0 to 9.0.